Phyllodes tumors are very rare fibroepithelial tumors that comprise less than 1% of all solid breast lesions. They can be classified as benign, borderline, or malignant. Their appearance is very similar to fibroadenomas by radiographic and sonographic imaging modalities. Biopsy is the only proven course for a definitive diagnosis. Treatment options include but are not limited to wide local excision and mastectomy.
Case Presentation
A woman in her mid-20s was referred by her primary care physician to the breast clinic for a diagnostic mammogram and targeted left breast sonography examination. The patient presented with a crescent-shaped, palpable left breast mass. The mass was located in the upper and lower outer quadrants of the left breast, encompassing the area from the 12 o'clock to the 6 o'clock position. The mass had been present and palpable by physical examination for a period of more than two years. One year prior, the patient had a targeted left breast sonography examination performed by a local mobile breast care unit. She was given the most likely diagnosis of a benign fibroadenoma. Two months prior to the current examination, the breast mass began to grow at an alarming rate. The patient noticed skin changes and dimpling over the area of concern.
A diagnostic mammogram was obtained of both breasts for comparison purposes. Caudal-cranial (CC) and mediolateral oblique (MLO) views were taken. The right breast displayed normal, dense breast tissue (Fig. 1 ). The left breast demonstrated a large, dense mass that extended from near the nipple line, outward laterally (Fig. 2) . The MLO view of the mass allowed for an approximate measurement of 8 cm.
A targeted left breast sonography examination was performed using a General Electric 400 sonography machine and an 8-to 11-MHz linear array transducer. The breast was imaged in radial and antiradial fashion. Sonography demonstrated a large hypoechoic, heterogeneous mass encompassing a significant amount of the left breast. The borders of the mass appeared lobulated anteriorly and undefined posteriorly ( Fig. 3A-C) . The normal breast tissue architecture appeared distorted with unrecognizable borders. Color Doppler was used and demonstrated increased vascularity throughout the mass in question ( Fig. 4) . A biopsy was suggested and performed one week later.
A biopsy of the breast mass was conducted, and four core samples were taken from the 2 o'clock position using sonographic guidance ( Fig. 5 ). An 18-gauge Bio-Pince needle was used to obtain the tissue samples, which ranged in size from 1.7 cm to 2.2 cm. Surgical pathology reported a diagnosis of malignant phyllodes tumor of the left breast. Following the final pathological diagnosis, the patient underwent a complete mastectomy of the left breast and continues to be followed and monitored for possible recurrence.
Discussion
Phyllodes tumors of the breast are rare neoplasms of fibroepithelial origin that comprise 0.3% to 1.0% of all breast tumors found in women. [1] [2] [3] [4] [5] [6] Phyllodes tumors were originally known as cystosarcoma phyllodes, which described the tumor's leaf-like appearance. 1, 5 Today, the term phyllodes tumor is used instead of cystosarcoma phyllodes.
Phyllodes tumors can be classified into three categories: benign, borderline, and malignant. These tumors are most often benign in origin; however, approximately 15% are found to be of a malignant nature. 3 Phyllodes tumors are most likely to present as stable breast masses with some exceptions, in which the tumor can demonstrate a rapid growth in size over a short period of time, spanning from a few weeks to months. 3, 5 Phyllodes tumors that demonstrate rapid growth are more likely to be classified as borderline or malignant. Phyllodes tumors are usually found in the upper, outer quadrant of the breast. The median age of presentation is 45 years old. 5 Phyllodes tumors are found more often in women of Latin American or Asian descent. 1, [3] [4] [5] Mammographically, phyllodes tumors appear as dense lesions with sharply defined margins and possible lobulated borders. 3, 4 The tumor can display a halo when imaged due to the compression of the surrounding breast tissue. 5 It is impossible to distinguish the difference between a fibroadenoma and a phyllodes tumor by mammography alone. 3, 4 The sonographic appearance of a phyllodes tumor is nearly indistinguishable from that of a fibroadenoma. Phyllodes tumors present as solid lesions that tend to be hypoechoic and heteroge- neous in comparison to surrounding breast tissue. 1, [4] [5] [6] They will display posterior acoustic enhancement, not shadowing. The borders tend to be smooth but lobulated. [3] [4] [5] Fluid-filled cysts can sometimes be observed within the tumor. 1, [3] [4] [5] The diagnosis for phyllodes tumors can only be made from histological observations. [1] [2] [3] [4] [5] [6] Core sample biopsies are performed most often to obtain an adequate tissue sampling for diagnosis. Differentials for a phyllodes tumor can include but are not limited to fibroadenomas, lipomas, galactoceles, posttraumatic oil cysts from fat necrosis, and hamartomas. Phyllodes tumors are most often treated by surgical means. [1] [2] [3] [4] [5] [6] Wide local excision is used for most benign phyllodes tumors, whereas mastectomy is the treatment of choice for borderline and malignant phyllodes tumors. The chance for recurrence is possible if the tumor excision is incomplete.
Conclusion
Phyllodes tumors are very rare fibroepithelial neoplasms that comprise less than 1% of all solid breast lesions. They can be classified into three categories: benign, borderline, or malignant. The sonographic appearance of a phyllodes tumor is very similar to that of a fibroadenoma. Biopsy is the only proven course for obtaining a definitive diagnosis of the lesion. Wide local excision and mastectomy are two of the treatment options, depending on the tumor tissue classification. This case report illustrates the sonographic findings of a malignant phyllodes of the breast in a patient in her mid-20s and demonstrates the importance of a sonographer's role in the complete assessment and evaluation of breast masses, including patient outcome.
